Protection against experimental nervous system autoimmune diseases by a human immunodeficiency virus-1 Tat peptide-based polyvalent vaccine

✍ Scribed by Hermann J. Schluesener

• Publisher: John Wiley and Sons
• Year: 1996
• Tongue: English
• Weight: 444 KB
• Volume: 46
• Category: Article
• ISSN: 0360-4012
• DOI: 10.1002/(sici)1097-4547(19961015)46:2<258::aid-jnr14>3.0.co;2-z

✦ Synopsis

The human immunodeficiency virus-1 (HIV-1) Tat peptide is taken up by a variety of cells in vitro and in vivo (Anderson et al.: